NCT00273702View on ClinicalTrials.gov

An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

September 30, 2006

Conditions
Pathological Gambling
Interventions
DRUG

N-Acetyl Cysteine

Trial Locations (1)

55454

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT00273702 - An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling | Biotech Hunter | Biotech Hunter